Dupilumab shows safety and efficacy for up to four years in treatment of moderate-to-severe atopic dermatitis in adults.

Patients with psoriasis are at an increased risk of developing alopecia areata.

Microbotox is effective in treating mild-to-moderate acne vulgaris and erythematotelangiectatic rosacea, according to a new study.

Patients with AD are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus vs dupilumab alone.

Registration is open for the inaugural Atopic Dermatitis Summit. The virtual even will be held on Saturday, April 23, 2022 at 10am EDT.

A new study has shown that internalized skin bias negatively imacts the mental health and QoL of patients with hidradenitis suppurativa.

A pre-clinical comparative study has shown that 1,064 nm lasers may be most effective in tattoo removal.

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis.